When it comes to accurate blood pressure readings, cuff size matters
In a new study from Johns Hopkins, researchers found using the wrong size cuff can lead to incorrect blood pressure readings and misdiagnosis.
They found...
COVID-19 booster critical as vaccine-induced antibodies wane in 6 months, don’t protect against Omicron
In a new study from Ohio State University, researchers found neutralizing antibody levels produced by two-dose mRNA vaccines against the original and early variants...
Blueberries could improve your cognitive function
In a study from the University of Cincinnati, researchers found blueberry supplementation improves memory in older adults.
The prevalence of dementia is increasing with the...
2 in 5 COVID-19 survivors have a new disability, study finds
In a recent study published in Critical Care, researchers found six months after recovering from COVID-19 critical illness, one in five people had died, and...
Scientists reveal the genetic causes of fatty liver disease
Over the past 40 years, changes in our urban environment and diet have had a major impact on our lifestyles.
We are more sedentary and...
Retiree doesn’t let heart issues slow him down
A few months before the pandemic, Chris Mathews was 20 miles into a 32-mile ride with his bicycle club when he lost all strength...
Severe COVID-19 may increase risk for PTSD in family members
In a new study from Paris University, researchers found family members of patients hospitalized in the intensive care unit (ICU) with COVID-19 experience a...
Healthy gut microbiome could improve cancer therapy
In a new study from King's College London, researchers found that the gut microbiome plays an important role in each patient’s response to cancer...
Researchers find balanced treatment for high-risk prostate cancer
In a new study from Northwestern University, researchers found that patients receiving radiotherapy to treat high-risk prostate cancer also benefit from androgen deprivation therapy.
The...
Scientists find possible cause for treatment resistance in skin cancer
Many melanoma patients are treated with drugs called BRAF or MEK inhibitors that specifically target the mutant proteins created in cancerous tumors.
These inhibitors can...